RT Journal Article
SR Electronic
T1 443 Pembrolizumab for BCG refractory non-muscle invasive bladder cancer yields poor recurrence-free survival and high toxicity in patients
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A492
OP A492
DO 10.1136/jitc-2023-SITC2023.0443
VO 11
IS Suppl 1
A1 Golijanin, Borivoj
A1 Bhatt, Vikas
A1 Amin, Ali
A1 Lagos, Galina
A1 Souza, Andre De
A1 Mega, Anthony E
A1 Golijanin, Dragan
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A492.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.